“Diane is a deeply experienced technologist and proven business leader with a very impressive track record growing businesses at world-class tech companies,” said Nick Grouf, Member of the Neural Analytics’ Board of Directors. “Her knowledge and expertise, specifically in commercializing data driven & machine learning businesses, will be invaluable as we continue to expand the adoption of our product offerings.”
Bryant has more than three decades of executive leadership in enterprise IT solutions. Most recently, she served as the chief operating officer of Google Cloud, where she focused on driving the scale and reach of the business including acceleration of customer adoption and development of next generation solutions. Prior to Google, Bryant spent 32 years at Intel. The last five years of which she was the president of the Data Center Group, including Intel’s healthcare business, growing it to $19 billion in revenue in 2017. Before becoming group president, she served as corporate vice president and chief information officer, responsible for the corporate-wide information technology solutions and services that enable Intel’s business.
“This is a very exciting time to be joining Neural Analytics. Through the application of technology, we have the opportunity to transform brain health care management. By applying machine learning, Neural Analytics’ Lucid Robotic System can enable physicians to quickly recognize and diagnose critical brain conditions to tremendously improve patient care,” said Diane Bryant, Neural Analytics Chairman and CEO. “I look forward to leading this strong team and driving adoption of the technology.”
Diane Bryant serves on the boards of directors for United Technologies Corporation (UTC), Broadcom Inc. (AVGO), several technology-based start-ups and the University of California, Davis Chancellor’s Board of Advisors and the school’s College of Engineering Board of Advisors.
During 2019, Neural Analytics announced the completion of a $25M Series C offering to support the commercial launch of its second-generation product, the Lucid Robotic System, and expand the market reach of its platform. Additionally, Neural Analytics enrolled the first patients into its CODEX Study that aims to broaden the collection of neurovascular data and explore the application of its technology in a wide range of neurological diseases.